| Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy GC Baldeviano, JG Barin, MV Talor, S Srinivasan, D Bedja, D Zheng, ... Circulation research 106 (10), 1646-1655, 2010 | 367 | 2010 |
| Etanercept plus standard therapy for Wegener's granulomatosis Wegener's Granulomatosis Etanercept Trial (WGET) Research Group New England Journal of Medicine 352 (4), 351-361, 2005 | 364 | 2005 |
| Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial JH Stone Arthritis & Rheumatism: Official Journal of the American College of …, 2003 | 350 | 2003 |
| Cardiac fibroblasts mediate IL-17A–driven inflammatory dilated cardiomyopathy L Wu, SF Ong, MV Talor, JG Barin, GC Baldeviano, DA Kass, D Bedja, ... Journal of Experimental Medicine 211 (7), 1449-1464, 2014 | 181 | 2014 |
| Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation D Cihakova, JG Barin, M Afanasyeva, M Kimura, DL Fairweather, M Berg, ... The American journal of pathology 172 (5), 1195-1208, 2008 | 181 | 2008 |
| Quantitative analysis of myocardial inflammation by flow cytometry in murine autoimmune myocarditis: correlation with cardiac function M Afanasyeva, D Georgakopoulos, DF Belardi, AC Ramsundar, JG Barin, ... The American journal of pathology 164 (3), 807-815, 2004 | 163 | 2004 |
| Macrophages participate in IL‐17‐mediated inflammation JG Barin, GC Baldeviano, MV Talor, L Wu, SF Ong, F Quader, P Chen, ... European journal of immunology 42 (3), 726-736, 2012 | 134 | 2012 |
| Design of the Wegener's granulomatosis etanercept trial (WGET) TWR Group Controlled clinical trials 23 (4), 450-468, 2002 | 107 | 2002 |
| Natural killer cells limit cardiac inflammation and fibrosis by halting eosinophil infiltration SF Ong, DL Ligons, JG Barin, L Wu, MV Talor, N Diny, JA Fontes, ... The American journal of pathology 185 (3), 847-861, 2015 | 90 | 2015 |
| Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA) MV Talor, JH Stone, J Stebbing, J Barin, NR Rose, CL Burek Clinical & Experimental Immunology 150 (1), 42-48, 2007 | 89 | 2007 |
| Eosinophil-derived IL-4 drives progression of myocarditis to inflammatory dilated cardiomyopathy NL Diny, GC Baldeviano, MV Talor, JG Barin, SF Ong, D Bedja, AG Hays, ... Journal of Experimental Medicine 214 (4), 943-957, 2017 | 87 | 2017 |
| IL-33 independently induces eosinophilic pericarditis and cardiac dilation: ST2 improves cardiac function ED Abston, JG Barin, D Cihakova, A Bucek, MJ Coronado, JE Brandt, ... Circulation: Heart Failure 5 (3), 366-375, 2012 | 76 | 2012 |
| Macrophage diversity in cardiac inflammation: a review JG Barin, NR Rose, D Čiháková Immunobiology 217 (5), 468-475, 2012 | 68 | 2012 |
| Fatal eosinophilic myocarditis develops in the absence of IFN-γ and IL-17A JG Barin, GC Baldeviano, MV Talor, L Wu, SF Ong, DL Fairweather, ... The Journal of Immunology 191 (8), 4038-4047, 2013 | 66 | 2013 |
| Macrophages and cardiac fibroblasts are the main producers of eotaxins and regulate eosinophil trafficking to the heart NL Diny, X Hou, JG Barin, G Chen, MV Talor, J Schaub, SD Russell, ... European journal of immunology 46 (12), 2749-2760, 2016 | 62 | 2016 |
| The cardiac microenvironment instructs divergent monocyte fates and functions in myocarditis X Hou, G Chen, W Bracamonte-Baran, HS Choi, NL Diny, J Sung, ... Cell reports 28 (1), 172-189. e7, 2019 | 59 | 2019 |
| Susceptibility to autoimmune myocarditis is associated with intrinsic differences in CD4+ T cells P Chen, GC Baldeviano, DL Ligons, MV Talor, JG Barin, NR Rose, ... Clinical & Experimental Immunology 169 (2), 79-88, 2012 | 59 | 2012 |
| Iodination of murine thyroglobulin enhances autoimmune reactivity in the NOD.H2h4 mouse JG Barin, MV Talor, RB Sharma, NR Rose, CL Burek Clinical & Experimental Immunology 142 (2), 251-259, 2005 | 59 | 2005 |
| Complete Freund's adjuvant induces experimental autoimmune myocarditis by enhancing IL‐6 production during initiation of the immune response JA Fontes, JG Barin, MV Talor, N Stickel, J Schaub, NR Rose, D Čiháková Immunity, inflammation and disease 5 (2), 163-176, 2017 | 55 | 2017 |
| Pathogenic IL‐23 signaling is required to initiate GM‐CSF‐driven autoimmune myocarditis in mice L Wu, NL Diny, SF Ong, JG Barin, X Hou, NR Rose, MV Talor, D Čiháková European journal of immunology 46 (3), 582-592, 2016 | 52 | 2016 |
